Insurance & Coding
CPT codes, payer policies, and reimbursement strategies
There is no dedicated CPT code for leech therapy. Practitioners must use unlisted or analogous codes, which complicates reimbursement. Coverage is generally limited to the FDA-cleared indication (venous congestion in flaps, grafts, and replants). Off-label indications are rarely covered by commercial insurers. The self-pay market is the primary revenue model for outpatient hirudotherapy practices.
Procedure Coding
| Code | System | Description | Application |
|---|---|---|---|
| 17999 | CPT | Unlisted procedure, skin/mucous membrane/subcutaneous tissue | Primary code for leech application procedure |
| C1765 | HCPCS | Adhesion barrier | Leech supply (hospital outpatient) |
| 97602 | CPT | Non-selective wound care debridement | Occasionally used; Status B (bundled) — no separate Medicare payment |
Use of unlisted code 17999 requires submission of operative/procedure notes, a cover letter explaining the nature of the service, and supporting documentation to justify medical necessity. Reimbursement is determined on a case-by-case basis.
Aetna Clinical Policy Bulletin 0556
Medically Necessary (Covered)
- Poor venous drainage (venous congestion/outflow obstruction)
- Salvage of vascularly compromised flaps (muscle, skin, fat tissue)
- Salvage of vascularly compromised replants
These align directly with the FDA 510(k)-cleared indications.
Not Covered
- Use after rhinoplasty
- All other indications not listed above
Rationale: “insufficient evidence of safety and effectiveness” (Aetna, 2024). This is the most explicit commercial insurance policy addressing medicinal leech therapy.
Other Major Payers
Commercial Insurers
Blue Cross Blue Shield, UnitedHealthcare, and Cigna have not published clinical policy bulletins specifically addressing leech therapy. Coverage is adjudicated case-by-case, typically requiring: performance in a hospital or accredited surgical center, physician order, FDA-cleared indication, prior authorization, and adequate medical necessity documentation.
Medicare & Medicaid
Medicare: No national coverage determination (NCD) or local coverage determination (LCD) exists. No dedicated HCPCS code. In the inpatient setting, leeches are typically billed as part of the DRG payment. Outpatient separate payment is not assured.
Medicaid: Coverage varies by state. No specific Medicaid policy addressing leech therapy has been identified.
Self-Pay Pricing
Typical Outpatient Fee Structure
| Parameter | Typical Value |
|---|---|
| Session fee | ~$200 |
| Leeches per session | 3-7 (determined by practitioner) |
| Session duration | 30-90 minutes |
| Sessions per course | 7-9 (1-2 per week) |
| Total course cost | $1,400-$1,800 |
| Leech procurement cost | $8-$15 per leech from FDA-cleared suppliers |
Some clinics offer package pricing for multi-session courses. A session using 5 leeches costs approximately $40-$75 in supplies alone, before disposables, PPE, antibiotic prescriptions, and practitioner time.
Cost-Effectiveness Evidence
Economic Justification
A 2021 study in Plastic and Reconstructive Surgery examined cost efficiency of varying durations of leech therapy for revascularized digits with venous congestion. In the hospital setting, leech therapy cost must be weighed against re-operation for venous anastomosis revision — which carries substantially higher surgical, anesthesia, and recovery costs. Published flap salvage rates of 60-83% support cost-effectiveness relative to flap loss.
For non-surgical indications (e.g., knee OA), a course of 7-9 sessions ($1,400-$1,800) compares favorably to intra-articular hyaluronic acid ($500-$2,000/course), PRP injections ($500-$2,500/injection), and total knee arthroplasty ($30,000-$50,000). However, head-to-head cost-effectiveness studies have not been conducted.
Documentation for Reimbursement
Maximizing Reimbursement Probability
- Detailed procedure note: Clinical indication, number/placement of leeches, duration, outcome
- Clinical photographs: Before, during, and after — documenting venous congestion and response
- Literature citations: Supporting evidence for the specific indication
- Letter of medical necessity: From the ordering physician (for non-surgeon applicators)
- FDA clearance documentation: Copy of 510(k) summary if requested by payer